171 related articles for article (PubMed ID: 27114600)
1. The First Step to Integrating Adapted Common Terminology Criteria for Adverse Events for Children.
de Rojas T; Bautista FJ; Madero L; Moreno L
J Clin Oncol; 2016 Jun; 34(18):2196-7. PubMed ID: 27114600
[No Abstract] [Full Text] [Related]
2. PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events.
Movsas B
JAMA Oncol; 2015 Nov; 1(8):1059-60. PubMed ID: 26270250
[No Abstract] [Full Text] [Related]
3. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Dueck AC; Mendoza TR; Mitchell SA; Reeve BB; Castro KM; Rogak LJ; Atkinson TM; Bennett AV; Denicoff AM; O'Mara AM; Li Y; Clauser SB; Bryant DM; Bearden JD; Gillis TA; Harness JK; Siegel RD; Paul DB; Cleeland CS; Schrag D; Sloan JA; Abernethy AP; Bruner DW; Minasian LM; Basch E;
JAMA Oncol; 2015 Nov; 1(8):1051-9. PubMed ID: 26270597
[TBL] [Abstract][Full Text] [Related]
4. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Bennett AV; Dueck AC; Mitchell SA; Mendoza TR; Reeve BB; Atkinson TM; Castro KM; Denicoff A; Rogak LJ; Harness JK; Bearden JD; Bryant D; Siegel RD; Schrag D; Basch E;
Health Qual Life Outcomes; 2016 Feb; 14():24. PubMed ID: 26892667
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.
Mendoza TR; Dueck AC; Bennett AV; Mitchell SA; Reeve BB; Atkinson TM; Li Y; Castro KM; Denicoff A; Rogak LJ; Piekarz RL; Cleeland CS; Sloan JA; Schrag D; Basch E
Clin Trials; 2017 Jun; 14(3):255-263. PubMed ID: 28545337
[TBL] [Abstract][Full Text] [Related]
6. Imaging of acute and subacute toxicities of cancer therapy in children.
Chavhan GB; Babyn PS; Nathan PC; Kaste SC
Pediatr Radiol; 2016 Jan; 46(1):9-20; quiz 6-8. PubMed ID: 26459011
[TBL] [Abstract][Full Text] [Related]
7. Late effects in childhood cancer survivors and survivorship issues.
Haupt R; Jankovic M; Hjorth L; Skinner R
Epidemiol Prev; 2013; 37(1 Suppl 1):266-73. PubMed ID: 23585450
[No Abstract] [Full Text] [Related]
8. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
9. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
10. Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data.
Tao C; Du J; Cai Y; Chen Y
Stud Health Technol Inform; 2015; 216():1076. PubMed ID: 26262375
[TBL] [Abstract][Full Text] [Related]
11. Late effects of treatment in children with cancer.
Neglia JP
Semin Pediatr Surg; 1993 Feb; 2(1):29-36. PubMed ID: 8062020
[TBL] [Abstract][Full Text] [Related]
12. Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.
Elzagallaai AA; Greff M; Rieder MJ
Clin Pharmacol Ther; 2017 Jun; 101(6):725-735. PubMed ID: 28295234
[TBL] [Abstract][Full Text] [Related]
13. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0.
Chen AP; Setser A; Anadkat MJ; Cotliar J; Olsen EA; Garden BC; Lacouture ME
J Am Acad Dermatol; 2012 Nov; 67(5):1025-39. PubMed ID: 22502948
[TBL] [Abstract][Full Text] [Related]
14. [Adverse drug reactions in children].
Jaffan L; Läer S
Ther Umsch; 2011 Jan; 68(1):34-40. PubMed ID: 21184392
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in neonates: could we be documenting more?
Hawcutt DB; O'Connor O; Turner MA
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
[TBL] [Abstract][Full Text] [Related]
16. [Childhood cancer surviving].
Tabone MD; Sommelet D
Arch Pediatr; 2006 Jun; 13(6):607-9. PubMed ID: 16690270
[No Abstract] [Full Text] [Related]
17. Treating paediatric malignancies.
Stevens R
Practitioner; 1992 Apr; 236(1513):395-8. PubMed ID: 1454702
[No Abstract] [Full Text] [Related]
18. The late effects of cancer therapy in childhood.
Morris Jones PH
Br J Cancer; 1991 Jul; 64(1):1-2. PubMed ID: 1854606
[No Abstract] [Full Text] [Related]
19. The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.
Reeve BB; Withycombe JS; Baker JN; Hooke MC; Lyons JC; Mowbray C; Wang J; Freyer DR; Joffe S; Sung L; Tomlinson D; Gold SH; Hinds PS
Pediatr Blood Cancer; 2013 Jul; 60(7):1231-6. PubMed ID: 23335328
[TBL] [Abstract][Full Text] [Related]
20. Severity of health conditions identified in a pediatric cancer survivor program.
Wasilewski-Masker K; Mertens AC; Patterson B; Meacham LR
Pediatr Blood Cancer; 2010 Jul; 54(7):976-82. PubMed ID: 20108334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
